PetMed Express Inc. Common Stock (PETS)
Stock · NASDAQ · Consumer Staples
$1.18as of 10/16/2026
Price chart
Active signals
PETS Signal Track Record
How signals performed across all stocks →What PETS's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 41 | -7.7% | 34% | September 25, 2026 |
| Bollinger Band Breakdown | 27 | -4.7% | 37% | September 11, 2026 |
| Bollinger Band Breakout | 18 | -4.2% | 39% | July 1, 2026 |
| 200-Day Moving Average TouchActive now | 9 | -11.1% | 11% | February 17, 2026 |
| Any 20-session window (baseline) | -5.7% | 30% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About PETS
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products…
- Sector
- Consumer Staples
- Industry
- Retail-Drug Stores and Proprietary Stores
- Employees
- 189
- Website
- www.1800petmeds.com/
Fundamentals
- 1-day range
- $1.2$1.27
- Market cap
- $42.10M
- P/E (trailing)
- —
- P/E (forward)
- -40.00
- EPS (trailing)
- $-1.39
- Dividend yield
- —
- Beta
- 0.82
- Avg. volume
- 107.7K
- Ex-dividend date
- August 11, 2023
- Dividend pay date
- August 18, 2023
How PetMed Express Inc. Common Stock Makes Money
Where the revenue actually goes — FY2026 annual results
Source: 10-K filed Jun 2, 2026 · via SEC EDGAR / Finnhub
Forecasts
1 analyst ratings
PetMed Express Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- PETSPetMed Express Inc. Common Stock$1.18▼ 3.28%Market cap $42.10MP/E —$1.26$4.1
- YI111 Inc. American Depositary Shares$3.13▲ 1.29%Market cap $33.34MP/E —$2.48$11.17
- RDGTRidgetech Inc. Ordinary Shares$0.84▲ 1.20%Market cap $2.85MP/E 0.24$0.67$760.5
- GRDNGuardian Pharmacy Services Inc. Class A Common Stock$39.47▼ 0.53%Market cap $2.50BP/E 38.13$23.37$48.33
- CVSCVS Health Corporation Common Stock$92.36▼ 0.24%Market cap $122.77BP/E 23.91$69.51$110.68
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| PETS PetMed Express Inc. Common Stock | $42.10M | — | $1.18 | ▼ 3.28% | $1.26$4.1 |
| YI 111 Inc. American Depositary Shares | $33.34M | — | $3.13 | ▲ 1.29% | $2.48$11.17 |
| RDGT Ridgetech Inc. Ordinary Shares | $2.85M | 0.24 | $0.84 | ▲ 1.20% | $0.67$760.5 |
| GRDN Guardian Pharmacy Services Inc. Class A Common Stock | $2.50B | 38.13 | $39.47 | ▼ 0.53% | $23.37$48.33 |
| CVS CVS Health Corporation Common Stock | $122.77B | 23.91 | $92.36 | ▼ 0.24% | $69.51$110.68 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Morgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $1.4Benzinga · 9/25/2026
- PetMeds Enhances Board of Directors with Appointment of Tamar Elkeles as New Independent DirectorYahoo · 9/21/2026
- PetMeds Appoints Jeff Willard as CEO & President and Announces Board Leadership TransitionYahoo · 9/17/2026
- PetMeds Appoints Andrew Parry as Chief Technology OfficerYahoo · 9/14/2026
Insider Activity
Insider Actions →- Elkeles Tamar · September 17, 2026 · Grant49.9K
- Campbell Leslie C.G. · August 11, 2026 · Grant60.0K
- Batushansky Peter · August 11, 2026 · Grant55.6K
- Mennen Justin L. · August 11, 2026 · Grant55.6K
- LaCamp James · August 11, 2026 · Grant55.6K
- KRULIK DOUGLAS · June 26, 2026 · Grant32.5K
- NINA CAPITAL HOLDINGS INC. · June 8, 2026 · Buy25.0K @ $1.75
Institutional Ownership
March 31, 2026
- Total shares held
- 5.91M
- Total value held
- $13.31M
- Institutional holders
- 47
- Unknown1.19M
- Unknown831.4K
- Unknown666.8K
- Unknown551.7K
- Unknown514.5K
- Unknown233.7K
- Unknown221.5K
- Unknown207.8K
- Unknown193.7K
- Unknown132.7K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
Morgan Stanley Lowers PETS Target to $1.40
Morgan Stanley has kept its underweight view on PETS but cut its price target to $1.40. The rating signals the firm expects the stock to trade below its current level. With the RSI near 19, the shares are in oversold territory and near a support level of $1.96. This downgrade may influence investor sentiment.
Morgan Stanley Lowers PETS Target to $1.40. Morgan Stanley has kept its underweight view on PETS but cut its price target to $1.40. The rating signals the firm expects the stock to trade below its current level. With the RSI near 19, the shares are in oversold territory and near a support level of $1.96. This downgrade may influence investor sentiment.